Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

REtrieval And cure of Chronic Hepatitis C (REACH): results of micro-elimination in the Utrecht province.

Kracht PAM, Arends JE, van Erpecum KJ, Thijsen SFT, Vlaminckx BJM, Weersink AJL, Wensing AMJ, Deege MPH, Dimmendaal M, Stadhouders PHGM, Friederich PW, Verhagen MAMT, Boland GJ, Hoepelman AIM.

Liver Int. 2018 Sep 11. doi: 10.1111/liv.13959. [Epub ahead of print]

PMID:
30204289
2.

Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma.

Auslander N, Zhang G, Lee JS, Frederick DT, Miao B, Moll T, Tian T, Wei Z, Madan S, Sullivan RJ, Boland G, Flaherty K, Herlyn M, Ruppin E.

Nat Med. 2018 Aug 20. doi: 10.1038/s41591-018-0157-9. [Epub ahead of print]

PMID:
30127394
3.

CT and MRI Protocol Variation and Optimization at an Academic Medical Center.

Glazer DI, DiPiro PJ, Shinagare AB, Huang RY, Wang A, Boland GW, Khorasani R.

J Am Coll Radiol. 2018 Sep;15(9):1254-1258. doi: 10.1016/j.jacr.2018.06.002. Epub 2018 Aug 3.

PMID:
30082232
4.

Toward Minimal Residual Disease-Directed Therapy in Melanoma.

Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M, Adriaens C, Radaelli E, Wolter P, Bechter O, Dummer R, Levesque M, Piris A, Frederick DT, Boland G, Flaherty KT, van den Oord J, Voet T, Aerts S, Lund AW, Marine JC.

Cell. 2018 Aug 9;174(4):843-855.e19. doi: 10.1016/j.cell.2018.06.025. Epub 2018 Jul 12.

PMID:
30017245
5.

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR).

BMC Infect Dis. 2018 Jun 1;18(1):251. doi: 10.1186/s12879-018-3161-2.

6.

Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.

Echevarría-Vargas IM, Reyes-Uribe PI, Guterres AN, Yin X, Kossenkov AV, Liu Q, Zhang G, Krepler C, Cheng C, Wei Z, Somasundaram R, Karakousis G, Xu W, Morrissette JJ, Lu Y, Mills GB, Sullivan RJ, Benchun M, Frederick DT, Boland G, Flaherty KT, Weeraratna AT, Herlyn M, Amaravadi R, Schuchter LM, Burd CE, Aplin AE, Xu X, Villanueva J.

EMBO Mol Med. 2018 May;10(5). pii: e8446. doi: 10.15252/emmm.201708446.

7.

Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.

Zhang G, Wu LW, Mender I, Barzily-Rokni M, Hammond MR, Ope O, Cheng C, Vasilopoulos T, Randell S, Sadek N, Beroard A, Xiao M, Tian T, Tan J, Saeed U, Sugarman E, Krepler C, Brafford P, Sproesser K, Murugan S, Somasundaram R, Garman B, Wubbenhorst B, Woo J, Yin X, Liu Q, Frederick DT, Miao B, Xu W, Karakousis GC, Xu X, Schuchter LM, Mitchell TC, Kwong LN, Amaravadi RK, Lu Y, Boland GM, Wei Z, Nathanson K, Herbig U, Mills GB, Flaherty KT, Herlyn M, Shay JW.

Clin Cancer Res. 2018 Mar 21. doi: 10.1158/1078-0432.CCR-17-2773. [Epub ahead of print]

PMID:
29563139
8.

Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.

Freidl GS, Tostmann A, Curvers M, Ruijs WLM, Smits G, Schepp R, Duizer E, Boland G, de Melker H, van der Klis FRM, Hautvast JLA, Veldhuijzen IK.

Vaccine. 2018 Mar 14;36(12):1664-1672. doi: 10.1016/j.vaccine.2018.01.079. Epub 2018 Feb 14.

9.

Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence.

Singleton KR, Crawford L, Tsui E, Manchester HE, Maertens O, Liu X, Liberti MV, Magpusao AN, Stein EM, Tingley JP, Frederick DT, Boland GM, Flaherty KT, McCall SJ, Krepler C, Sproesser K, Herlyn M, Adams DJ, Locasale JW, Cichowski K, Mukherjee S, Wood KC.

Cell Rep. 2017 Dec 5;21(10):2796-2812. doi: 10.1016/j.celrep.2017.11.022.

10.

A Serum Protein Signature Associated with Outcome after Anti-PD-1 Therapy in Metastatic Melanoma.

Weber JS, Sznol M, Sullivan RJ, Blackmon S, Boland G, Kluger HM, Halaban R, Bacchiocchi A, Ascierto PA, Capone M, Oliveira C, Meyer K, Grigorieva J, Asmellash SG, Roder J, Roder H.

Cancer Immunol Res. 2018 Jan;6(1):79-86. doi: 10.1158/2326-6066.CIR-17-0412. Epub 2017 Dec 5.

PMID:
29208646
11.

Lymphatic versus Hematogenous Melanoma Metastases: Support for Biological Heterogeneity without Clear Clinical Application.

Kasumova GG, Haynes AB, Boland GM.

J Invest Dermatol. 2017 Dec;137(12):2466-2468. doi: 10.1016/j.jid.2017.08.029.

PMID:
29169461
12.

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.

Deng J, Wang ES, Jenkins RW, Li S, Dries R, Yates K, Chhabra S, Huang W, Liu H, Aref AR, Ivanova E, Paweletz CP, Bowden M, Zhou CW, Herter-Sprie GS, Sorrentino JA, Bisi JE, Lizotte PH, Merlino AA, Quinn MM, Bufe LE, Yang A, Zhang Y, Zhang H, Gao P, Chen T, Cavanaugh ME, Rode AJ, Haines E, Roberts PJ, Strum JC, Richards WG, Lorch JH, Parangi S, Gunda V, Boland GM, Bueno R, Palakurthi S, Freeman GJ, Ritz J, Haining WN, Sharpless NE, Arthanari H, Shapiro GI, Barbie DA, Gray NS, Wong KK.

Cancer Discov. 2018 Feb;8(2):216-233. doi: 10.1158/2159-8290.CD-17-0915. Epub 2017 Nov 3.

PMID:
29101163
13.

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Cañadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA.

Cancer Discov. 2018 Feb;8(2):196-215. doi: 10.1158/2159-8290.CD-17-0833. Epub 2017 Nov 3.

PMID:
29101162
14.

Resistance to checkpoint blockade therapy through inactivation of antigen presentation.

Sade-Feldman M, Jiao YJ, Chen JH, Rooney MS, Barzily-Rokni M, Eliane JP, Bjorgaard SL, Hammond MR, Vitzthum H, Blackmon SM, Frederick DT, Hazar-Rethinam M, Nadres BA, Van Seventer EE, Shukla SA, Yizhak K, Ray JP, Rosebrock D, Livitz D, Adalsteinsson V, Getz G, Duncan LM, Li B, Corcoran RB, Lawrence DP, Stemmer-Rachamimov A, Boland GM, Landau DA, Flaherty KT, Sullivan RJ, Hacohen N.

Nat Commun. 2017 Oct 26;8(1):1136. doi: 10.1038/s41467-017-01062-w.

15.

Atypical ALK-positive Spitz tumors with 9p21 homozygous deletion: Report of two cases and review of the literature.

Rand AJ, Flejter WL, Dowling CA, Brooke LM, Boland GM, Kroshinsky D, Rosenblum IR, Hernandez-Perez M, Reimann JDR.

J Cutan Pathol. 2018 Feb;45(2):136-140. doi: 10.1111/cup.13057. Epub 2017 Nov 28. Review.

PMID:
29028122
16.

PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.

Lu H, Liu S, Zhang G, Bin Wu, Zhu Y, Frederick DT, Hu Y, Zhong W, Randell S, Sadek N, Zhang W, Chen G, Cheng C, Zeng J, Wu LW, Zhang J, Liu X, Xu W, Krepler C, Sproesser K, Xiao M, Miao B, Liu J, Song CD, Liu JY, Karakousis GC, Schuchter LM, Lu Y, Mills G, Cong Y, Chernoff J, Guo J, Boland GM, Sullivan RJ, Wei Z, Field J, Amaravadi RK, Flaherty KT, Herlyn M, Xu X, Guo W.

Nature. 2017 Oct 5;550(7674):133-136. doi: 10.1038/nature24040. Epub 2017 Sep 27.

17.

Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee.

Mayo-Smith WW, Song JH, Boland GL, Francis IR, Israel GM, Mazzaglia PJ, Berland LL, Pandharipande PV.

J Am Coll Radiol. 2017 Aug;14(8):1038-1044. doi: 10.1016/j.jacr.2017.05.001. Epub 2017 Jun 23.

PMID:
28651988
18.

Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.

Larimer BM, Wehrenberg-Klee E, Dubois F, Mehta A, Kalomeris T, Flaherty K, Boland G, Mahmood U.

Cancer Res. 2017 May 1;77(9):2318-2327. doi: 10.1158/0008-5472.CAN-16-3346.

19.

Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.

Vitiello M, Tuccoli A, D'Aurizio R, Sarti S, Giannecchini L, Lubrano S, Marranci A, Evangelista M, Peppicelli S, Ippolito C, Barravecchia I, Guzzolino E, Montagnani V, Gowen M, Mercoledi E, Mercatanti A, Comelli L, Gurrieri S, Wu LW, Ope O, Flaherty K, Boland GM, Hammond MR, Kwong L, Chiariello M, Stecca B, Zhang G, Salvetti A, Angeloni D, Pitto L, Calorini L, Chiorino G, Pellegrini M, Herlyn M, Osman I, Poliseno L.

Oncotarget. 2017 Apr 11;8(15):25395-25417. doi: 10.18632/oncotarget.15915.

20.

JOURNAL CLUB: Structured Feedback From Patients on Actual Radiology Reports: A Novel Approach to Improve Reporting Practices.

Gunn AJ, Gilcrease-Garcia B, Mangano MD, Sahani DV, Boland GW, Choy G.

AJR Am J Roentgenol. 2017 Jun;208(6):1262-1270. doi: 10.2214/AJR.16.17584. Epub 2017 Apr 12.

PMID:
28402133
21.

An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer.

Zerillo JA, Schouwenburg MG, van Bommel ACM, Stowell C, Lippa J, Bauer D, Berger AM, Boland G, Borras JM, Buss MK, Cima R, Van Cutsem E, van Duyn EB, Finlayson SRG, Hung-Chun Cheng S, Langelotz C, Lloyd J, Lynch AC, Mamon HJ, McAllister PK, Minsky BD, Ngeow J, Abu Hassan MR, Ryan K, Shankaran V, Upton MP, Zalcberg J, van de Velde CJ, Tollenaar R; Colorectal Cancer Working Group of the International Consortium for Health Outcomes Measurement (ICHOM).

JAMA Oncol. 2017 May 1;3(5):686-694. doi: 10.1001/jamaoncol.2017.0417.

PMID:
28384684
22.

The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy.

Raigani S, Cohen S, Boland GM.

Curr Oncol Rep. 2017 Mar;19(3):17. doi: 10.1007/s11912-017-0575-8. Review.

PMID:
28251494
23.

Report of the ACR's Economics Committee on Value-Based Payment Models.

Boland GW, Glenn L, Goldberg-Stein S, Jha S, Mangano M, Patel S, Schoppe KA, Seidenwurm D, Lohnes J, Silva E 3rd, Abramson R, Durand DJ, Pattie L, Kassing P, Heller RE 3rd.

J Am Coll Radiol. 2017 Jan;14(1):6-14. doi: 10.1016/j.jacr.2016.08.031. Erratum in: J Am Coll Radiol. 2017 Mar;14 (3):448.

PMID:
28061965
24.

Metastatic melanoma with spontaneous complete regression of a thick primary lesion.

Khosravi H, Akabane AL, Alloo A, Nazarian RM, Boland GM.

JAAD Case Rep. 2016 Dec 3;2(6):439-441. eCollection 2016 Nov. No abstract available.

25.

The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.

Newsum AM, Ho CK, Lieveld FI, van de Laar TJ, Koekkoek SM, Rebers SP, van der Meer JT, Wensing AM, Boland GJ, Arends JE, van Erpecum KJ, Prins M, Molenkamp R, Schinkel J.

AIDS. 2017 Jan 2;31(1):105-112.

PMID:
27898592
26.

Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.

Stoof SP, van Ravenhorst MB, van Rooijen DM, de Voer RM, van der Klis FR, Boland GJ, Sanders EA, Berbers GA, Teunis PF.

Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00429-16. doi: 10.1128/CVI.00429-16. Print 2017 Feb.

27.

Academic Medical Centers and Community Hospitals Integration: Trends and Strategies.

Fleishon HB, Itri JN, Boland GW, Duszak R Jr.

J Am Coll Radiol. 2017 Jan;14(1):45-51. doi: 10.1016/j.jacr.2016.07.006. Epub 2016 Nov 1.

PMID:
27815052
28.

Differing Interpretations of Report Terminology Between Primary Care Physicians and Radiologists.

Gunn AJ, Tuttle MC, Flores EJ, Mangano MD, Bennett SE, Sahani DV, Choy G, Boland GW.

J Am Coll Radiol. 2016 Dec;13(12 Pt A):1525-1529.e1. doi: 10.1016/j.jacr.2016.07.016. Epub 2016 Aug 30.

PMID:
27595196
29.

 Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection.

Lieveld FI, Swaans N, Newsum AM, Ho CK, Schinkel J, Molenkamp R, van der Meer JT, Arends JE, Hoepelman AI, Wensing AM, Siersema PD, van Erpecum KJ, Boland GJ.

Ann Hepatol. 2016 Sep-Oct;15(5):696-704. doi: 10.5604/16652681.1212426.

30.

Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.

Gouma S, Ten Hulscher HI, Schurink-van 't Klooster TM, de Melker HE, Boland GJ, Kaaijk P, van Els CACM, Koopmans MPG, van Binnendijk RS.

Vaccine. 2016 Jul 29;34(35):4166-4171. doi: 10.1016/j.vaccine.2016.06.063. Epub 2016 Jun 29.

PMID:
27372154
31.

T2 relaxation time is related to liver fibrosis severity.

Guimaraes AR, Siqueira L, Uppal R, Alford J, Fuchs BC, Yamada S, Tanabe K, Chung RT, Lauwers G, Chew ML, Boland GW, Sahani DV, Vangel M, Hahn PF, Caravan P.

Quant Imaging Med Surg. 2016 Apr;6(2):103-14. doi: 10.21037/qims.2016.03.02.

32.

Bacterial Epimerization as a Route for Deoxynivalenol Detoxification: the Influence of Growth and Environmental Conditions.

He JW, Hassan YI, Perilla N, Li XZ, Boland GJ, Zhou T.

Front Microbiol. 2016 Apr 21;7:572. doi: 10.3389/fmicb.2016.00572. eCollection 2016.

33.

Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma.

Khor CC, Do T, Jia H, Nakano M, George R, Abu-Amero K, Duvesh R, Chen LJ, Li Z, Nongpiur ME, Perera SA, Qiao C, Wong HT, Sakai H, Barbosa de Melo M, Lee MC, Chan AS, Azhany Y, Dao TL, Ikeda Y, Perez-Grossmann RA, Zarnowski T, Day AC, Jonas JB, Tam PO, Tran TA, Ayub H, Akhtar F, Micheal S, Chew PT, Aljasim LA, Dada T, Luu TT, Awadalla MS, Kitnarong N, Wanichwecharungruang B, Aung YY, Mohamed-Noor J, Vijayan S, Sarangapani S, Husain R, Jap A, Baskaran M, Goh D, Su DH, Wang H, Yong VK, Yip LW, Trinh TB, Makornwattana M, Nguyen TT, Leuenberger EU, Park KH, Wiyogo WA, Kumar RS, Tello C, Kurimoto Y, Thapa SS, Pathanapitoon K, Salmon JF, Sohn YH, Fea A, Ozaki M, Lai JS, Tantisevi V, Khaing CC, Mizoguchi T, Nakano S, Kim CY, Tang G, Fan S, Wu R, Meng H, Nguyen TT, Tran TD, Ueno M, Martinez JM, Ramli N, Aung YM, Reyes RD, Vernon SA, Fang SK, Xie Z, Chen XY, Foo JN, Sim KS, Wong TT, Quek DT, Venkatesh R, Kavitha S, Krishnadas SR, Soumittra N, Shantha B, Lim BA, Ogle J, de Vasconcellos JP, Costa VP, Abe RY, de Souza BB, Sng CC, Aquino MC, Kosior-Jarecka E, Fong GB, Tamanaja VC, Fujita R, Jiang Y, Waseem N, Low S, Pham HN, Al-Shahwan S, Craven ER, Khan MI, Dada R, Mohanty K, Faiq MA, Hewitt AW, Burdon KP, Gan EH, Prutthipongsit A, Patthanathamrongkasem T, Catacutan MA, Felarca IR, Liao CS, Rusmayani E, Istiantoro VW, Consolandi G, Pignata G, Lavia C, Rojanapongpun P, Mangkornkanokpong L, Chansangpetch S, Chan JC, Choy BN, Shum JW, Than HM, Oo KT, Han AT, Yong VH, Ng XY, Goh SR, Chong YF, Hibberd ML, Seielstad M, Png E, Dunstan SJ, Chau NV, Bei J, Zeng YX, Karkey A, Basnyat B, Pasutto F, Paoli D, Frezzotti P, Wang JJ, Mitchell P, Fingert JH, Allingham RR, Hauser MA, Lim ST, Chew SH, Ebstein RP, Sakuntabhai A, Park KH, Ahn J, Boland G, Snippe H, Stead R, Quino R, Zaw SN, Lukasik U, Shetty R, Zahari M, Bae HW, Oo NL, Kubota T, Manassakorn A, Ho WL, Dallorto L, Hwang YH, Kiire CA, Kuroda M, Djamal ZE, Peregrino JI, Ghosh A, Jeoung JW, Hoan TS, Srisamran N, Sandragasu T, Set SH, Doan VH, Bhattacharya SS, Ho CL, Tan DT, Sihota R, Loon SC, Mori K, Kinoshita S, Hollander AI, Qamar R, Wang YX, Teo YY, Tai ES, Hartleben-Matkin C, Lozano-Giral D, Saw SM, Cheng CY, Zenteno JC, Pang CP, Bui HT, Hee O, Craig JE, Edward DP, Yonahara M, Neto JM, Guevara-Fujita ML, Xu L, Ritch R, Liza-Sharmini AT, Wong TY, Al-Obeidan S, Do NH, Sundaresan P, Tham CC, Foster PJ, Vijaya L, Tashiro K, Vithana EN, Wang N, Aung T.

Nat Genet. 2016 May;48(5):556-62. doi: 10.1038/ng.3540. Epub 2016 Apr 4.

PMID:
27064256
34.

A Roadmap for Value-Based Payments.

Boland GW, Duszak R Jr.

J Am Coll Radiol. 2016 Feb;13(2):170-2. doi: 10.1016/j.jacr.2015.10.003. Epub 2015 Nov 19. No abstract available.

PMID:
26777737
35.

Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma.

Roland CL, Boland GM, Demicco EG, Lusby K, Ingram D, May CD, Kivlin CM, Watson K, Al Sannaa GA, Wang WL, Ravi V, Pollock RE, Lev D, Cormier JN, Hunt KK, Feig BW, Lazar AJ, Torres KE.

JAMA Surg. 2016 Apr;151(4):347-54. doi: 10.1001/jamasurg.2015.4205.

36.

The Haptic Radiologist: Being There, Always.

Kaura D, Blickman JG, Boland GW.

J Am Coll Radiol. 2016 Jan;13(1):104-5. doi: 10.1016/j.jacr.2015.10.010. Epub 2015 Nov 21. No abstract available.

PMID:
26614411
37.

Principles of Melanoma Staging.

Boland GM, Gershenwald JE.

Cancer Treat Res. 2016;167:131-48. doi: 10.1007/978-3-319-22539-5_5. Review.

PMID:
26601861
38.

Radiologist Point-of-Care Clinical Decision Support and Adherence to Guidelines for Incidental Lung Nodules.

Lu MT, Rosman DA, Wu CC, Gilman MD, Harvey HB, Gervais DA, Alkasab TK, Shepard JA, Boland GW, Pandharipande PV.

J Am Coll Radiol. 2016 Feb;13(2):156-62. doi: 10.1016/j.jacr.2015.09.029. Epub 2015 Nov 11.

PMID:
26577875
39.

Radiology Malpractice Claims in the United States From 2008 to 2012: Characteristics and Implications.

Harvey HB, Tomov E, Babayan A, Dwyer K, Boland S, Pandharipande PV, Halpern EF, Alkasab TK, Hirsch JA, Schaefer PW, Boland GW, Choy G.

J Am Coll Radiol. 2016 Feb;13(2):124-30. doi: 10.1016/j.jacr.2015.07.013. Epub 2015 Oct 9.

PMID:
26454772
40.

Modality Access: Strategies for Optimizing Throughput.

Boland GW, Duszak R Jr.

J Am Coll Radiol. 2015 Oct;12(10):1073-5. doi: 10.1016/j.jacr.2015.06.012. No abstract available.

PMID:
26435120
41.

Re: "Patients Prefer Results From the Ordering Provider and Access to Their Radiology Reports".

Gunn AJ, Mangano M, Choy G, Sahani DV, Boland GW.

J Am Coll Radiol. 2015 Oct;12(10):1006. doi: 10.1016/j.jacr.2015.06.023. No abstract available.

PMID:
26435112
42.

Structured Reporting and Communication.

Boland GW, Duszak R Jr.

J Am Coll Radiol. 2015 Dec;12(12 Pt A):1286-8. doi: 10.1016/j.jacr.2015.08.001. Epub 2015 Sep 28. No abstract available.

PMID:
26421851
43.

Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8.

He JW, Bondy GS, Zhou T, Caldwell D, Boland GJ, Scott PM.

Food Chem Toxicol. 2015 Oct;84:250-9. doi: 10.1016/j.fct.2015.09.003. Epub 2015 Sep 9.

PMID:
26363308
44.

Low serum hyaluronic acid levels associated with spontaneous HBsAg clearance.

Harkisoen S, Arends JE, van den Hoek A, van Erpecum KJ, Boland GJ, Hoepelman AI.

Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2183-9. doi: 10.1007/s10096-015-2467-x. Epub 2015 Aug 21.

45.

Protocol management and design: current and future best practices.

Boland GW, Duszak R Jr.

J Am Coll Radiol. 2015 Aug;12(8):833-5. doi: 10.1016/j.jacr.2015.04.021. No abstract available.

PMID:
26250976
46.

An epimer of deoxynivalenol: purification and structure identification of 3-epi-deoxynivalenol.

He JW, Yang R, Zhou T, Boland GJ, Scott PM, Bondy GS.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32(9):1523-30. doi: 10.1080/19440049.2015.1072771. Epub 2015 Aug 6.

PMID:
26247304
47.

Melanoma: Advances in Targeted Therapy and Molecular Markers.

DePeralta DK, Boland GM.

Ann Surg Oncol. 2015 Oct;22(11):3451-8. doi: 10.1245/s10434-015-4702-1. Epub 2015 Jul 30. Review.

PMID:
26224403
48.

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).

Hermans LE, Svicher V, Pas SD, Salpini R, Alvarez M, Ben Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Weis N, Yalcinkaya T, Lepej SZ, Perno C, Boucher CA, Wensing AM; HEPVIR Working Group of the European Society for Translational Antiviral Research.

J Infect Dis. 2016 Jan 1;213(1):39-48. doi: 10.1093/infdis/jiv363. Epub 2015 Jul 1.

PMID:
26136470
49.

Imaging Appropriateness and Implementation of Clinical Decision Support.

Boland GW, Weilburg J, Duszak R Jr.

J Am Coll Radiol. 2015 Jun;12(6):601-3. doi: 10.1016/j.jacr.2015.03.014. No abstract available.

PMID:
26047400
50.

Clinical next generation sequencing to identify actionable aberrations in a phase I program.

Boland GM, Piha-Paul SA, Subbiah V, Routbort M, Herbrich SM, Baggerly K, Patel KP, Brusco L, Horombe C, Naing A, Fu S, Hong DS, Janku F, Johnson A, Broaddus R, Luthra R, Shaw K, Mendelsohn J, Mills GB, Meric-Bernstam F.

Oncotarget. 2015 Aug 21;6(24):20099-110.

Supplemental Content

Loading ...
Support Center